Enzymatica AB (Sweden) Profile

SEK 0.08  2.87%

Enzymatica AB Summary

Enzymatica AB (ENZY) is traded on Stockholm Stock Exchange in Sweden. It is located in Ideon Science Park and employs 23 people. The company currently falls under 'Small-Cap' category with current market capitalization of 346.28 M. Enzymatica AB operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 90.89 M outstanding shares. ENZYMATICA has accumulated about 8.19 M in cash with (15.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.09.
Check Enzymatica AB Probability Of Bankruptcy

Target Price Odds Analysis

Odds Below 2.71HorizonTargetOdds Above 2.71
0.69%30 days 2.71 99.30%
Based on normal probability distribution, the odds of Enzymatica AB to move above current price in 30 days from now is close to 99% (This Enzymatica AB probability density function shows the probability of Enzymatica AB Stock to fall within a particular range of prices over 30 days) .

Enzymatica AB Risk Profiles

Key Fundamentals

Enzymatica AB Against Markets

Current Ratings

Enzymatica AB 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
Financial Distress (0 to 100%)
Equity ratings for Enzymatica AB are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Enzymatica AB , a life science company, develops and sells medical device products against infectious-related diseases. The company was founded in 2007 and is headquartered in Lund, Sweden. Enzymatica AB operates under Pharmaceuticals And Biosciences classification in Sweden and traded on Stockholm Stock Exchange. It employs 23 people. more
NameEnzymatica AB
Chairman of the BoardBengt BaronView All
Macroaxis Advice
Healthcare, Pharmaceuticals And Biosciences
InstrumentSweden Stock View All
Business AddressIdeon Science Park
Foreign Associate  USA
ExchangeStockholm Stock Exchange
IndustryPharmaceuticals And Biosciences
Phone46 4 62 86 31 00
CurrencySEK - Swedish Kronor

Enzymatica AB Corporate Directors

Jonas Forsberg Director, MBA
Anders Jungbeck Director
Nils Siegbahn Director, Ph.D
Additionally see Investing Opportunities. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.